Pelthos Therapeutics has secured the rights to market non-fluorinated quinolone antimicrobial, Xepi (ozenoxacin) Cream, 1% in ...

SanegeneBio has formed a research and licensing partnership with Eli Lilly and Company to develop RNAi candidates for ...

From 18-20 November, Formulated Solutions will be attending the Florida Innovation Conference, held by BioFlorida, at the Walt Disney ...

Abzena and Mabqi have announced a partnership integrating antibody discovery capabilities with development and manufacturing ...

Approval of J&J's Darzalex marks a milestone for high-risk sMM patients, but GlobalData analyst Biswajit Podder believes ...

Though the FDA has requested no new data, the additional information reflects a major amendment to Rhythm’s supplemental new ...

Alvotech and Advanz Pharma have announced the receipt of marketing authorisations from the MHRA for all four formulations of ...

Novo Nordisk’s oral therapy Wegovy (semaglutide) reduced cardiovascular risk factors in the Phase III OASIS 4 trial. Being ...

US consumer health company Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for ...

Cencora is set to invest $1bn by 2030 to expand its US pharmaceutical distribution network, adding resilience and capacity.

ADCs remain à la mode in the oncology sector, with Merck & Co (MSD) tying up another deal to advance its pipeline in the ...

Eli Lilly and Company has outlined plans to develop a $3bn manufacturing facility in Katwijk, Leiden Bio Science Park, the ...